Evaluation of the potential of Pap test fluid and cervical swabs to serve as clinical diagnostic biospecimens for the detection of ovarian cancer by mass spectrometry-based proteomics

Abstract

The purpose of this study was to determine whether the residual fixative from a liquid-based Pap test or a swab of the cervix contained proteins that were also found in the primary tumor of a woman with high grade serous ovarian cancer. This study is the first step in determining the feasibility of using the liquid-based Pap test or a cervical swab for the detection of ovarian cancer protein biomarkers.

Document Details

Document Type
Pub Defense Publication
Publication Date
Jan 07, 2021
Source ID
10.1186/s12014-020-09309-3

Entities

People

  • Amy P N Skubitz
  • Kristin L. M. Boylan
  • Melissa A. Geller
  • Peter A. Argenta
  • Somaieh Afiuni-zadeh
  • Timothy J. Griffin

Organizations

  • Minnesota Ovarian Cancer Alliance
  • United States Department of Defense

Tags

Readers

  • Oncology and Biomarker-Based Cancer Detection.
  • Women's Health and Cancer Risk Research: African American Women and Pregnancy Outcomes.

Technology Areas

  • Biotechnology